AnalystsAsthika GoonewardeneAsthika Goonewardene's Stock Forecasts
AnalystsAsthika Goonewardene
Sectors:
Industries:
Analyst Ranking
Top 38%
#1599 out of 4241 analysts
Average Return
+0.62%
Win Rate
45%15 out of 33
Risk vs Reward
Poor
Good
Asthika Goonewardene's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunogen IncIMGN | +222.56% | $5.32 | $17.16 | 2022-11-20 - 2023-06-09 | Strong Buy |
Forty Seven IncFTSV | +163.68% | $35.74 | $94.24 | 2020-01-12 - 2020-03-03 | Strong Buy |
Sutro Biopharma IncSTRO | +111.24% | $12.01 | $25.37 | 2020-01-12 - 2021-01-13 | Strong Buy |
Genmab AGMAB | +89.09% | $22.65 | $42.83 | 2020-01-12 - 2021-01-13 | Strong Buy |
Mersana Therapeutics IncMRSN | +34.43% | $6.36 | $8.55 | 2022-11-20 - 2023-06-09 | Strong Buy |
Asthika Goonewardene Analyst Color
Get additional color on Asthika Goonewardene's coverage of popular stocks
Asthika Goonewardene's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Immunogen IncIMGN | 2 | Strong Buy | $18.00 | +4.90% | Maintains | 5 days ago |
Arcellx IncACLX | 1 | Strong Buy | $60.00 | +49.51% | Initiates Coverage On | 24 days ago |
Instil Bio IncTIL | 1 | Hold | $6.00 | +916.95% | Reinstates | 2 months ago |
Igm Biosciences IncIGMS | 4 | Strong Buy | $25.00 | +135.40% | Maintains | 2 months ago |
Hookipa Pharma IncHOOK | 3 | Strong Buy | $4.00 | +296.04% | Maintains | 3 months ago |
Tcr2 Therapeutics IncTCRR | 3 | Hold | $3.00 | +102.70% | Downgrades | 3 months ago |
Iovance Biotherapeutics IncIOVA | 1 | Strong Buy | $17.00 | +115.46% | Maintains | 5 months ago |
Sutro Biopharma IncSTRO | 3 | Strong Buy | $25.00 | +369.04% | Maintains | 5 months ago |
Harpoon Therapeutics IncHARP | 3 | Hold | $2.00 | +173.22% | Downgrades | 6 months ago |
Mersana Therapeutics IncMRSN | 1 | Strong Buy | $12.00 | +40.35% | Initiates Coverage On | 7 months ago |
Seagen IncSGEN | 1 | Hold | $135.00 | -31.33% | Initiates Coverage On | 7 months ago |
Celularity IncCELU | 3 | Hold | $6.00 | +817.43% | Maintains | 10 months ago |
Nextcure IncNXTC | 4 | Strong Buy | $15.00 | +803.61% | Maintains | 10 months ago |
Compugen LtdCGEN | 2 | Strong Buy | $4.00 | +205.34% | Maintains | 10 months ago |
Autolus Therapeutics PLCAUTL | 2 | Strong Buy | $11.00 | +283.28% | Maintains | a year ago |
Adicet Bio IncACET | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | a year ago |
Exelixis IncEXEL | 2 | Strong Buy | $36.00 | N/A | Maintains | 2 years ago |
Allogene Therapeutics IncALLO | 2 | Strong Buy | $41.00 | N/A | Upgrades | 2 years ago |
Forty Seven IncFTSV | 2 | Hold | $95.50 | N/A | Downgrades | 3 years ago |
Genmab AGMAB | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 3 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.